img

Global Disease Control and Prevention Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Disease Control and Prevention Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Vaccines are biological entity used to activate acquired immunity to control or prevent particular disease or a group of disease. Immunization is carried out in infants as well as in adults. Vaccination against various bacterial and viral diseases is an integral part of infectious disease control world-wide.
The global Disease Control and Prevention Vaccine market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Disease Control and Prevention Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Disease Control and Prevention Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Disease Control and Prevention Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Disease Control and Prevention Vaccine include GSK, Merck & Co., Inc, Pfizer, Sanofi, AstraZeneca PLC, Sinovac Biotech Ltd, Astellas Pharma Inc, Serum Institute of India Pvt. Ltd and Daiichi Sankyo, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Disease Control and Prevention Vaccine, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Disease Control and Prevention Vaccine by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Disease Control and Prevention Vaccine market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Disease Control and Prevention Vaccine market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


GSK
Merck & Co., Inc
Pfizer
Sanofi
AstraZeneca PLC
Sinovac Biotech Ltd
Astellas Pharma Inc
Serum Institute of India Pvt. Ltd
Daiichi Sankyo
By Type
Live-Attenuated
Inactivated
Recombinant Sub Unit and Toxoid
By Application
Pediatric Vaccine
Adult Vaccine
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Disease Control and Prevention Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Disease Control and Prevention Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Disease Control and Prevention Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Disease Control and Prevention Vaccine Definition
1.2 Market by Type
1.2.1 Global Disease Control and Prevention Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Live-Attenuated
1.2.3 Inactivated
1.2.4 Recombinant Sub Unit and Toxoid
1.3 Market Segment by Application
1.3.1 Global Disease Control and Prevention Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Pediatric Vaccine
1.3.3 Adult Vaccine
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Disease Control and Prevention Vaccine Sales
2.1 Global Disease Control and Prevention Vaccine Revenue Estimates and Forecasts 2018-2034
2.2 Global Disease Control and Prevention Vaccine Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Disease Control and Prevention Vaccine Revenue by Region
2.3.1 Global Disease Control and Prevention Vaccine Revenue by Region (2018-2024)
2.3.2 Global Disease Control and Prevention Vaccine Revenue by Region (2024-2034)
2.4 Global Disease Control and Prevention Vaccine Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Disease Control and Prevention Vaccine Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Disease Control and Prevention Vaccine Sales Quantity by Region
2.6.1 Global Disease Control and Prevention Vaccine Sales Quantity by Region (2018-2024)
2.6.2 Global Disease Control and Prevention Vaccine Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Disease Control and Prevention Vaccine Sales Quantity by Manufacturers
3.1.1 Global Disease Control and Prevention Vaccine Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Disease Control and Prevention Vaccine Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Disease Control and Prevention Vaccine Sales in 2022
3.2 Global Disease Control and Prevention Vaccine Revenue by Manufacturers
3.2.1 Global Disease Control and Prevention Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Disease Control and Prevention Vaccine Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Disease Control and Prevention Vaccine Revenue in 2022
3.3 Global Disease Control and Prevention Vaccine Sales Price by Manufacturers
3.4 Global Key Players of Disease Control and Prevention Vaccine, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Disease Control and Prevention Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Disease Control and Prevention Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Disease Control and Prevention Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Disease Control and Prevention Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Disease Control and Prevention Vaccine Sales Quantity by Type
4.1.1 Global Disease Control and Prevention Vaccine Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Disease Control and Prevention Vaccine Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Disease Control and Prevention Vaccine Sales Quantity Market Share by Type (2018-2034)
4.2 Global Disease Control and Prevention Vaccine Revenue by Type
4.2.1 Global Disease Control and Prevention Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Disease Control and Prevention Vaccine Forecasted Revenue by Type (2024-2034)
4.2.3 Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2018-2034)
4.3 Global Disease Control and Prevention Vaccine Price by Type
4.3.1 Global Disease Control and Prevention Vaccine Price by Type (2018-2024)
4.3.2 Global Disease Control and Prevention Vaccine Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Disease Control and Prevention Vaccine Sales Quantity by Application
5.1.1 Global Disease Control and Prevention Vaccine Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Disease Control and Prevention Vaccine Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Disease Control and Prevention Vaccine Sales Quantity Market Share by Application (2018-2034)
5.2 Global Disease Control and Prevention Vaccine Revenue by Application
5.2.1 Global Disease Control and Prevention Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Disease Control and Prevention Vaccine Forecasted Revenue by Application (2024-2034)
5.2.3 Global Disease Control and Prevention Vaccine Revenue Market Share by Application (2018-2034)
5.3 Global Disease Control and Prevention Vaccine Price by Application
5.3.1 Global Disease Control and Prevention Vaccine Price by Application (2018-2024)
5.3.2 Global Disease Control and Prevention Vaccine Price Forecast by Application (2024-2034)
6 North America
6.1 North America Disease Control and Prevention Vaccine Sales by Company
6.1.1 North America Disease Control and Prevention Vaccine Revenue by Company (2018-2024)
6.1.2 North America Disease Control and Prevention Vaccine Sales Quantity by Company (2018-2024)
6.2 North America Disease Control and Prevention Vaccine Market Size by Type
6.2.1 North America Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2034)
6.2.2 North America Disease Control and Prevention Vaccine Revenue by Type (2018-2034)
6.3 North America Disease Control and Prevention Vaccine Market Size by Application
6.3.1 North America Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2034)
6.3.2 North America Disease Control and Prevention Vaccine Revenue by Application (2018-2034)
6.4 North America Disease Control and Prevention Vaccine Market Size by Country
6.4.1 North America Disease Control and Prevention Vaccine Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Disease Control and Prevention Vaccine Revenue by Country (2018-2034)
6.4.3 North America Disease Control and Prevention Vaccine Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Disease Control and Prevention Vaccine Sales by Company
7.1.1 Europe Disease Control and Prevention Vaccine Sales Quantity by Company (2018-2024)
7.1.2 Europe Disease Control and Prevention Vaccine Revenue by Company (2018-2024)
7.2 Europe Disease Control and Prevention Vaccine Market Size by Type
7.2.1 Europe Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2034)
7.2.2 Europe Disease Control and Prevention Vaccine Revenue by Type (2018-2034)
7.3 Europe Disease Control and Prevention Vaccine Market Size by Application
7.3.1 Europe Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2034)
7.3.2 Europe Disease Control and Prevention Vaccine Revenue by Application (2018-2034)
7.4 Europe Disease Control and Prevention Vaccine Market Size by Country
7.4.1 Europe Disease Control and Prevention Vaccine Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Disease Control and Prevention Vaccine Revenue by Country (2018-2034)
7.4.3 Europe Disease Control and Prevention Vaccine Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Disease Control and Prevention Vaccine Sales by Company
8.1.1 China Disease Control and Prevention Vaccine Sales Quantity by Company (2018-2024)
8.1.2 China Disease Control and Prevention Vaccine Revenue by Company (2018-2024)
8.2 China Disease Control and Prevention Vaccine Market Size by Type
8.2.1 China Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2034)
8.2.2 China Disease Control and Prevention Vaccine Revenue by Type (2018-2034)
8.3 China Disease Control and Prevention Vaccine Market Size by Application
8.3.1 China Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2034)
8.3.2 China Disease Control and Prevention Vaccine Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Disease Control and Prevention Vaccine Sales by Company
9.1.1 APAC Disease Control and Prevention Vaccine Sales Quantity by Company (2018-2024)
9.1.2 APAC Disease Control and Prevention Vaccine Revenue by Company (2018-2024)
9.2 APAC Disease Control and Prevention Vaccine Market Size by Type
9.2.1 APAC Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2034)
9.2.2 APAC Disease Control and Prevention Vaccine Revenue by Type (2018-2034)
9.3 APAC Disease Control and Prevention Vaccine Market Size by Application
9.3.1 APAC Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2034)
9.3.2 APAC Disease Control and Prevention Vaccine Revenue by Application (2018-2034)
9.4 APAC Disease Control and Prevention Vaccine Market Size by Region
9.4.1 APAC Disease Control and Prevention Vaccine Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Disease Control and Prevention Vaccine Revenue by Region (2018-2034)
9.4.3 APAC Disease Control and Prevention Vaccine Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Disease Control and Prevention Vaccine Sales by Company
10.1.1 Middle East, Africa and Latin America Disease Control and Prevention Vaccine Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Disease Control and Prevention Vaccine Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Disease Control and Prevention Vaccine Market Size by Type
10.2.1 Middle East, Africa and Latin America Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Disease Control and Prevention Vaccine Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Disease Control and Prevention Vaccine Market Size by Application
10.3.1 Middle East, Africa and Latin America Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Disease Control and Prevention Vaccine Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Disease Control and Prevention Vaccine Market Size by Country
10.4.1 Middle East, Africa and Latin America Disease Control and Prevention Vaccine Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Disease Control and Prevention Vaccine Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Disease Control and Prevention Vaccine Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Overview
11.1.3 GSK Disease Control and Prevention Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 GSK Disease Control and Prevention Vaccine Products and Services
11.1.5 GSK Disease Control and Prevention Vaccine SWOT Analysis
11.1.6 GSK Recent Developments
11.2 Merck & Co., Inc
11.2.1 Merck & Co., Inc Company Information
11.2.2 Merck & Co., Inc Overview
11.2.3 Merck & Co., Inc Disease Control and Prevention Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Merck & Co., Inc Disease Control and Prevention Vaccine Products and Services
11.2.5 Merck & Co., Inc Disease Control and Prevention Vaccine SWOT Analysis
11.2.6 Merck & Co., Inc Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Disease Control and Prevention Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Pfizer Disease Control and Prevention Vaccine Products and Services
11.3.5 Pfizer Disease Control and Prevention Vaccine SWOT Analysis
11.3.6 Pfizer Recent Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Overview
11.4.3 Sanofi Disease Control and Prevention Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Sanofi Disease Control and Prevention Vaccine Products and Services
11.4.5 Sanofi Disease Control and Prevention Vaccine SWOT Analysis
11.4.6 Sanofi Recent Developments
11.5 AstraZeneca PLC
11.5.1 AstraZeneca PLC Company Information
11.5.2 AstraZeneca PLC Overview
11.5.3 AstraZeneca PLC Disease Control and Prevention Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 AstraZeneca PLC Disease Control and Prevention Vaccine Products and Services
11.5.5 AstraZeneca PLC Disease Control and Prevention Vaccine SWOT Analysis
11.5.6 AstraZeneca PLC Recent Developments
11.6 Sinovac Biotech Ltd
11.6.1 Sinovac Biotech Ltd Company Information
11.6.2 Sinovac Biotech Ltd Overview
11.6.3 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Products and Services
11.6.5 Sinovac Biotech Ltd Disease Control and Prevention Vaccine SWOT Analysis
11.6.6 Sinovac Biotech Ltd Recent Developments
11.7 Astellas Pharma Inc
11.7.1 Astellas Pharma Inc Company Information
11.7.2 Astellas Pharma Inc Overview
11.7.3 Astellas Pharma Inc Disease Control and Prevention Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Astellas Pharma Inc Disease Control and Prevention Vaccine Products and Services
11.7.5 Astellas Pharma Inc Disease Control and Prevention Vaccine SWOT Analysis
11.7.6 Astellas Pharma Inc Recent Developments
11.8 Serum Institute of India Pvt. Ltd
11.8.1 Serum Institute of India Pvt. Ltd Company Information
11.8.2 Serum Institute of India Pvt. Ltd Overview
11.8.3 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Products and Services
11.8.5 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine SWOT Analysis
11.8.6 Serum Institute of India Pvt. Ltd Recent Developments
11.9 Daiichi Sankyo
11.9.1 Daiichi Sankyo Company Information
11.9.2 Daiichi Sankyo Overview
11.9.3 Daiichi Sankyo Disease Control and Prevention Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Daiichi Sankyo Disease Control and Prevention Vaccine Products and Services
11.9.5 Daiichi Sankyo Disease Control and Prevention Vaccine SWOT Analysis
11.9.6 Daiichi Sankyo Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Disease Control and Prevention Vaccine Value Chain Analysis
12.2 Disease Control and Prevention Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Disease Control and Prevention Vaccine Production Mode & Process
12.4 Disease Control and Prevention Vaccine Sales and Marketing
12.4.1 Disease Control and Prevention Vaccine Sales Channels
12.4.2 Disease Control and Prevention Vaccine Distributors
12.5 Disease Control and Prevention Vaccine Customers
13 Market Dynamics
13.1 Disease Control and Prevention Vaccine Industry Trends
13.2 Disease Control and Prevention Vaccine Market Drivers
13.3 Disease Control and Prevention Vaccine Market Challenges
13.4 Disease Control and Prevention Vaccine Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Disease Control and Prevention Vaccine Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Live-Attenuated
Table 3. Major Manufacturers of Inactivated
Table 4. Major Manufacturers of Recombinant Sub Unit and Toxoid
Table 5. Global Disease Control and Prevention Vaccine Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Disease Control and Prevention Vaccine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Disease Control and Prevention Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Disease Control and Prevention Vaccine Revenue Market Share by Region (2018-2024)
Table 9. Global Disease Control and Prevention Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 10. Global Disease Control and Prevention Vaccine Revenue Market Share by Region (2024-2034)
Table 11. Global Disease Control and Prevention Vaccine Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 12. Global Disease Control and Prevention Vaccine Sales by Region (2018-2024) & (K Units)
Table 13. Global Disease Control and Prevention Vaccine Sales Market Share by Region (2018-2024)
Table 14. Global Disease Control and Prevention Vaccine Sales by Region (2024-2034) & (K Units)
Table 15. Global Disease Control and Prevention Vaccine Sales Market Share by Region (2024-2034)
Table 16. Global Disease Control and Prevention Vaccine Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 17. Global Disease Control and Prevention Vaccine Sales Quantity Share by Manufacturers (2018-2024)
Table 18. Global Disease Control and Prevention Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Disease Control and Prevention Vaccine Revenue Share by Manufacturers (2018-2024)
Table 20. Global Disease Control and Prevention Vaccine Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Key Players of Disease Control and Prevention Vaccine, Industry Ranking, 2021 VS 2022
Table 22. Global Disease Control and Prevention Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Disease Control and Prevention Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Disease Control and Prevention Vaccine as of 2022)
Table 24. Global Key Manufacturers of Disease Control and Prevention Vaccine, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Disease Control and Prevention Vaccine, Product Offered and Application
Table 26. Global Key Manufacturers of Disease Control and Prevention Vaccine, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 29. Global Disease Control and Prevention Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 30. Global Disease Control and Prevention Vaccine Sales Quantity Share by Type (2018-2024)
Table 31. Global Disease Control and Prevention Vaccine Sales Quantity Share by Type (2024-2034)
Table 32. Global Disease Control and Prevention Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Disease Control and Prevention Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 34. Global Disease Control and Prevention Vaccine Revenue Share by Type (2018-2024)
Table 35. Global Disease Control and Prevention Vaccine Revenue Share by Type (2024-2034)
Table 36. Disease Control and Prevention Vaccine Price by Type (2018-2024) & (USD/Unit)
Table 37. Global Disease Control and Prevention Vaccine Price Forecast by Type (2024-2034) & (USD/Unit)
Table 38. Global Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 39. Global Disease Control and Prevention Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 40. Global Disease Control and Prevention Vaccine Sales Quantity Share by Application (2018-2024)
Table 41. Global Disease Control and Prevention Vaccine Sales Quantity Share by Application (2024-2034)
Table 42. Global Disease Control and Prevention Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Disease Control and Prevention Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 44. Global Disease Control and Prevention Vaccine Revenue Share by Application (2018-2024)
Table 45. Global Disease Control and Prevention Vaccine Revenue Share by Application (2024-2034)
Table 46. Disease Control and Prevention Vaccine Price by Application (2018-2024) & (USD/Unit)
Table 47. Global Disease Control and Prevention Vaccine Price Forecast by Application (2024-2034) & (USD/Unit)
Table 48. North America Disease Control and Prevention Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 49. North America Disease Control and Prevention Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 50. North America Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 51. North America Disease Control and Prevention Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 52. North America Disease Control and Prevention Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 53. North America Disease Control and Prevention Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 54. North America Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 55. North America Disease Control and Prevention Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 56. North America Disease Control and Prevention Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 57. North America Disease Control and Prevention Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 58. North America Disease Control and Prevention Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 59. North America Disease Control and Prevention Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 60. North America Disease Control and Prevention Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 61. North America Disease Control and Prevention Vaccine Sales Quantity by Country (2018-2024) & (K Units)
Table 62. North America Disease Control and Prevention Vaccine Sales Quantity by Country (2024-2034) & (K Units)
Table 63. Europe Disease Control and Prevention Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 64. Europe Disease Control and Prevention Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 65. Europe Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 66. Europe Disease Control and Prevention Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 67. Europe Disease Control and Prevention Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 68. Europe Disease Control and Prevention Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 69. Europe Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 70. Europe Disease Control and Prevention Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 71. Europe Disease Control and Prevention Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 72. Europe Disease Control and Prevention Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 73. Europe Disease Control and Prevention Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 74. Europe Disease Control and Prevention Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 75. Europe Disease Control and Prevention Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 76. Europe Disease Control and Prevention Vaccine Sales Quantity by Country (2018-2024) & (K Units)
Table 77. Europe Disease Control and Prevention Vaccine Sales Quantity by Country (2024-2034) & (K Units)
Table 78. China Disease Control and Prevention Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 79. China Disease Control and Prevention Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 80. China Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 81. China Disease Control and Prevention Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 82. China Disease Control and Prevention Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 83. China Disease Control and Prevention Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 84. China Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 85. China Disease Control and Prevention Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 86. China Disease Control and Prevention Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 87. China Disease Control and Prevention Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 88. APAC Disease Control and Prevention Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 89. APAC Disease Control and Prevention Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 90. APAC Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 91. APAC Disease Control and Prevention Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 92. APAC Disease Control and Prevention Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 93. APAC Disease Control and Prevention Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 94. APAC Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 95. APAC Disease Control and Prevention Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 96. APAC Disease Control and Prevention Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 97. APAC Disease Control and Prevention Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 98. APAC Disease Control and Prevention Vaccine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 99. APAC Disease Control and Prevention Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 100. APAC Disease Control and Prevention Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 101. APAC Disease Control and Prevention Vaccine Sales Quantity by Region (2018-2024) & (K Units)
Table 102. APAC Disease Control and Prevention Vaccine Sales Quantity by Region (2024-2034) & (K Units)
Table 103. Middle East, Africa and Latin America Disease Control and Prevention Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 104. Middle East, Africa and Latin America Disease Control and Prevention Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Disease Control and Prevention Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 107. Middle East, Africa and Latin America Disease Control and Prevention Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 108. Middle East, Africa and Latin America Disease Control and Prevention Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 109. Middle East, Africa and Latin America Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 110. Middle East, Africa and Latin America Disease Control and Prevention Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 111. Middle East, Africa and Latin America Disease Control and Prevention Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 112. Middle East, Africa and Latin America Disease Control and Prevention Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 113. Middle East, Africa and Latin America Disease Control and Prevention Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 114. Middle East, Africa and Latin America Disease Control and Prevention Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 115. Middle East, Africa and Latin America Disease Control and Prevention Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America Disease Control and Prevention Vaccine Sales Quantity by Country (2018-2024) & (K Units)
Table 117. Middle East, Africa and Latin America Disease Control and Prevention Vaccine Sales Quantity by Country (2024-2034) & (K Units)
Table 118. GSK Company Information
Table 119. GSK Description and Overview
Table 120. GSK Disease Control and Prevention Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 121. GSK Disease Control and Prevention Vaccine Product and Services
Table 122. GSK Disease Control and Prevention Vaccine SWOT Analysis
Table 123. GSK Recent Developments
Table 124. Merck & Co., Inc Company Information
Table 125. Merck & Co., Inc Description and Overview
Table 126. Merck & Co., Inc Disease Control and Prevention Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 127. Merck & Co., Inc Disease Control and Prevention Vaccine Product and Services
Table 128. Merck & Co., Inc Disease Control and Prevention Vaccine SWOT Analysis
Table 129. Merck & Co., Inc Recent Developments
Table 130. Pfizer Company Information
Table 131. Pfizer Description and Overview
Table 132. Pfizer Disease Control and Prevention Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 133. Pfizer Disease Control and Prevention Vaccine Product and Services
Table 134. Pfizer Disease Control and Prevention Vaccine SWOT Analysis
Table 135. Pfizer Recent Developments
Table 136. Sanofi Company Information
Table 137. Sanofi Description and Overview
Table 138. Sanofi Disease Control and Prevention Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 139. Sanofi Disease Control and Prevention Vaccine Product and Services
Table 140. Sanofi Disease Control and Prevention Vaccine SWOT Analysis
Table 141. Sanofi Recent Developments
Table 142. AstraZeneca PLC Company Information
Table 143. AstraZeneca PLC Description and Overview
Table 144. AstraZeneca PLC Disease Control and Prevention Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 145. AstraZeneca PLC Disease Control and Prevention Vaccine Product and Services
Table 146. AstraZeneca PLC Disease Control and Prevention Vaccine SWOT Analysis
Table 147. AstraZeneca PLC Recent Developments
Table 148. Sinovac Biotech Ltd Company Information
Table 149. Sinovac Biotech Ltd Description and Overview
Table 150. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 151. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product and Services
Table 152. Sinovac Biotech Ltd Disease Control and Prevention Vaccine SWOT Analysis
Table 153. Sinovac Biotech Ltd Recent Developments
Table 154. Astellas Pharma Inc Company Information
Table 155. Astellas Pharma Inc Description and Overview
Table 156. Astellas Pharma Inc Disease Control and Prevention Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 157. Astellas Pharma Inc Disease Control and Prevention Vaccine Product and Services
Table 158. Astellas Pharma Inc Disease Control and Prevention Vaccine SWOT Analysis
Table 159. Astellas Pharma Inc Recent Developments
Table 160. Serum Institute of India Pvt. Ltd Company Information
Table 161. Serum Institute of India Pvt. Ltd Description and Overview
Table 162. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 163. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product and Services
Table 164. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine SWOT Analysis
Table 165. Serum Institute of India Pvt. Ltd Recent Developments
Table 166. Daiichi Sankyo Company Information
Table 167. Daiichi Sankyo Description and Overview
Table 168. Daiichi Sankyo Disease Control and Prevention Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 169. Daiichi Sankyo Disease Control and Prevention Vaccine Product and Services
Table 170. Daiichi Sankyo Disease Control and Prevention Vaccine SWOT Analysis
Table 171. Daiichi Sankyo Recent Developments
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Disease Control and Prevention Vaccine Distributors List
Table 175. Disease Control and Prevention Vaccine Customers List
Table 176. Disease Control and Prevention Vaccine Market Trends
Table 177. Disease Control and Prevention Vaccine Market Drivers
Table 178. Disease Control and Prevention Vaccine Market Challenges
Table 179. Disease Control and Prevention Vaccine Market Restraints
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Disease Control and Prevention Vaccine Product Picture
Figure 2. Global Disease Control and Prevention Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Disease Control and Prevention Vaccine Market Share by Type in 2022 & 2034
Figure 4. Live-Attenuated Product Picture
Figure 5. Inactivated Product Picture
Figure 6. Recombinant Sub Unit and Toxoid Product Picture
Figure 7. Global Disease Control and Prevention Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 8. Global Disease Control and Prevention Vaccine Market Share by Application in 2022 & 2034
Figure 9. Pediatric Vaccine
Figure 10. Adult Vaccine
Figure 11. Disease Control and Prevention Vaccine Report Years Considered
Figure 12. Global Disease Control and Prevention Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Disease Control and Prevention Vaccine Revenue 2018-2034 (US$ Million)
Figure 14. Global Disease Control and Prevention Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 15. Global Disease Control and Prevention Vaccine Sales Quantity 2018-2034 (K Units)
Figure 16. Global Disease Control and Prevention Vaccine Sales Quantity Market Share by Region (2018-2024)
Figure 17. Global Disease Control and Prevention Vaccine Sales Quantity Market Share by Region (2024-2034)
Figure 18. North America Disease Control and Prevention Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 19. North America Disease Control and Prevention Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 20. Europe Disease Control and Prevention Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 21. Europe Disease Control and Prevention Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 22. China Disease Control and Prevention Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 23. China Disease Control and Prevention Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 24. APAC Disease Control and Prevention Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 25. APAC Disease Control and Prevention Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Disease Control and Prevention Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 27. Middle East, Africa and Latin America Disease Control and Prevention Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by Disease Control and Prevention Vaccine Sales Quantity in 2022
Figure 29. The Top 10 and Top 5 Players Market Share by Disease Control and Prevention Vaccine Revenue in 2022
Figure 30. Disease Control and Prevention Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Disease Control and Prevention Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 32. Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2018-2034)
Figure 33. Global Disease Control and Prevention Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 34. Global Disease Control and Prevention Vaccine Revenue Market Share by Application (2018-2034)
Figure 35. North America Disease Control and Prevention Vaccine Revenue Market Share by Company in 2022
Figure 36. North America Disease Control and Prevention Vaccine Sales Quantity Market Share by Company in 2022
Figure 37. North America Disease Control and Prevention Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 38. North America Disease Control and Prevention Vaccine Revenue Market Share by Type (2018-2034)
Figure 39. North America Disease Control and Prevention Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 40. North America Disease Control and Prevention Vaccine Revenue Market Share by Application (2018-2034)
Figure 41. North America Disease Control and Prevention Vaccine Revenue Share by Country (2018-2034)
Figure 42. North America Disease Control and Prevention Vaccine Sales Quantity Share by Country (2018-2034)
Figure 43. U.S. Disease Control and Prevention Vaccine Revenue (2018-2034) & (US$ Million)
Figure 44. Canada Disease Control and Prevention Vaccine Revenue (2018-2034) & (US$ Million)
Figure 45. Europe Disease Control and Prevention Vaccine Sales Quantity Market Share by Company in 2022
Figure 46. Europe Disease Control and Prevention Vaccine Revenue Market Share by Company in 2022
Figure 47. Europe Disease Control and Prevention Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 48. Europe Disease Control and Prevention Vaccine Revenue Market Share by Type (2018-2034)
Figure 49. Europe Disease Control and Prevention Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 50. Europe Disease Control and Prevention Vaccine Revenue Market Share by Application (2018-2034)
Figure 51. Europe Disease Control and Prevention Vaccine Revenue Share by Country (2018-2034)
Figure 52. Europe Disease Control and Prevention Vaccine Sales Quantity Share by Country (2018-2034)
Figure 53. Germany Disease Control and Prevention Vaccine Revenue (2018-2034) & (US$ Million)
Figure 54. France Disease Control and Prevention Vaccine Revenue (2018-2034) & (US$ Million)
Figure 55. U.K. Disease Control and Prevention Vaccine Revenue (2018-2034) & (US$ Million)
Figure 56. Italy Disease Control and Prevention Vaccine Revenue (2018-2034) & (US$ Million)
Figure 57. Russia Disease Control and Prevention Vaccine Revenue (2018-2034) & (US$ Million)
Figure 58. China Disease Control and Prevention Vaccine Sales Quantity Market Share by Company in 2022
Figure 59. China Disease Control and Prevention Vaccine Revenue Market Share by Company in 2022
Figure 60. China Disease Control and Prevention Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 61. China Disease Control and Prevention Vaccine Revenue Market Share by Type (2018-2034)
Figure 62. China Disease Control and Prevention Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 63. China Disease Control and Prevention Vaccine Revenue Market Share by Application (2018-2034)
Figure 64. APAC Disease Control and Prevention Vaccine Sales Quantity Market Share by Company in 2022
Figure 65. APAC Disease Control and Prevention Vaccine Revenue Market Share by Company in 2022
Figure 66. APAC Disease Control and Prevention Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 67. APAC Disease Control and Prevention Vaccine Revenue Market Share by Type (2018-2034)
Figure 68. APAC Disease Control and Prevention Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 69. APAC Disease Control and Prevention Vaccine Revenue Market Share by Application (2018-2034)
Figure 70. APAC Disease Control and Prevention Vaccine Revenue Share by Region (2018-2034)
Figure 71. APAC Disease Control and Prevention Vaccine Sales Quantity Share by Region (2018-2034)
Figure 72. Japan Disease Control and Prevention Vaccine Revenue (2018-2034) & (US$ Million)
Figure 73. South Korea Disease Control and Prevention Vaccine Revenue (2018-2034) & (US$ Million)
Figure 74. China Taiwan Disease Control and Prevention Vaccine Revenue (2018-2034) & (US$ Million)
Figure 75. Southeast Asia Disease Control and Prevention Vaccine Revenue (2018-2034) & (US$ Million)
Figure 76. India Disease Control and Prevention Vaccine Revenue (2018-2034) & (US$ Million)
Figure 77. Middle East, Africa and Latin America Disease Control and Prevention Vaccine Sales Quantity Market Share by Company in 2022
Figure 78. Middle East, Africa and Latin America Disease Control and Prevention Vaccine Revenue Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America Disease Control and Prevention Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Disease Control and Prevention Vaccine Revenue Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Disease Control and Prevention Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Disease Control and Prevention Vaccine Revenue Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Disease Control and Prevention Vaccine Sales Quantity Share by Country (2018-2034)
Figure 84. Middle East, Africa and Latin America Disease Control and Prevention Vaccine Revenue Share by Country (2018-2034)
Figure 85. Brazil Disease Control and Prevention Vaccine Revenue (2018-2034) & (US$ Million)
Figure 86. Mexico Disease Control and Prevention Vaccine Revenue (2018-2034) & (US$ Million)
Figure 87. Turkey Disease Control and Prevention Vaccine Revenue (2018-2034) & (US$ Million)
Figure 88. Israel Disease Control and Prevention Vaccine Revenue (2018-2034) & (US$ Million)
Figure 89. GCC Countries Disease Control and Prevention Vaccine Revenue (2018-2034) & (US$ Million)
Figure 90. Disease Control and Prevention Vaccine Value Chain
Figure 91. Disease Control and Prevention Vaccine Production Process
Figure 92. Channels of Distribution (Direct Vs Distribution)
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries